| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/23/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 390 | $12.15 | $4.7k | | 03/21/2023 |
| 03/22/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 379 | $12.64 | $4.8k | | 03/21/2023 |
| 03/21/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 372 | $12.89 | $4.8k | | 03/21/2023 |
| 03/20/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 380 | $12.61 | $4.8k | | 03/17/2023 |
| 03/17/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 360 | $13.28 | $4.8k | | 03/17/2023 |
| 03/16/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 357 | $13.43 | $4.8k | | 03/15/2023 |
| 03/15/2023 | Tarsus Pharmaceuticals, Inc. | | Exercise | Restricted Stock Units | 5.1k | $0.00 | $0 | | 03/15/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 48.1k | $15.00 | $721.7k | | 03/08/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 32.6k | $0.00 | $0 | | 03/08/2023 |
| 03/09/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 69.5k | $19.59 | $1.4M | | 03/09/2022 |
| 03/09/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 20.4k | $0.00 | $0 | | 03/09/2022 |
| 01/07/2021 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 61.5k | $47.25 | $2.9M | | 01/07/2021 |